Structure of Sugammadex sodium CAS 343306 79 6 - Sugammadex sodium CAS 343306-79-6

Iden­ti­fi­ca­tion

CAS Number

343306-79-6

Name

Sug­am­madex sodium

Syn­onyms

3,3′,3”,3”’,3””,3””’,3”””,3”””’-{[(1S,3S,5S,6S,8S,10S,11S,13S,15S,16S,18S,20S,21S,23S,25S,26S,28S,30S,31S,33S,35S,36S,38S,40S,41R,42R,43R,44R,45R,46R,47R,48R,49R,50R,51R,52R,53R,54R,55R,56
;R)-41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56-Hexadécahydroxy-2,4,7,9,12,14,17,19,22,24,27,29,32,34,37,39-hexadécaoxanonacyclo[36.2.2.23,6.28,11.213,16.218,21.223,26.228,31.233,36]h
exapentacontane-5,10,15,20,25,30,35,40-octay [French] [ACD/IUPAC Name]
343306-79-6 [RN]
Octanatrium-3,3′,3”,3”’,3””,3””’,3”””,3”””’-{[(1S,3S,5S,6S,8S,10S,11S,13S,15S,16S,18S,20S,21S,23S,25S,26S,28S,30S,31S,33S,35S,36S,38S,40S,41R,42R,43R,44R,45R,46R,47R,48R,49R,50R,51R,52R,53
;R,54R,55R,56R)-41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56-hexadecahydroxy-2,4,7,9,12,14,17,19,22,24,27,29,32,34,37,39-hexadecaoxanonacyclo[36.2.2.23,6.28,11.213,16.218,21.223,26.228,31
.233,36]hexapentacontan-5,10,15,20,25,30, [Ger­man] [ACD/IUPAC Name]
Octa­sodi­um 3,3′,3”,3”’,3””,3””’,3”””,3”””’-{[(1S,3S,5S,6S,8S,10S,11S,13S,15S,16S,18S,20S,21S,23S,25S,26S,28S,30S,31S,33S,35S,36S,38S,40S,41R,42R,43R,44R,45R,46R,47R,48R,49R,50R,51R,52R,53R
;,54R,55R,56R)-41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56-hexadecahydroxy-2,4,7,9,12,14,17,19,22,24,27,29,32,34,37,39-hexadecaoxanonacyclo[36.2.2.23,6.28,11.213,16.218,21.223,26.228,31
.233,36]hexapentacontane-5,10,15,20,25,30, [ACD/IUPAC Name]
Sug­am­madex Sodi­um [USAN]
D05940
MFCD09954145
Sug­am­madex sodi­um (USAN)
SUY­DEX SODI­UM
UNII-ERJ6X2MXV7

SMILES

C(CSC[C@@H]1[C@@H]2[C@@H]([C@H]([C@H](O1)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)O)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5O)O)O[C@@H]6[C@H](O[C@@H]([C@@H]([C@H]6O)O)O[C@@H]7[C@H](O[C@@H]([C@@H]([C@H]7O)O)O[C@@H]8[C@H](O[C@@H]([C@@H]([C@H]😯)O)O[C@@H]9[C@H](O[C@H](O2)[C@@H]([C@H]9O)O)CSC­CC(=O)[O-])CSC­CC(=O)[O-])CSC­CC(=O)[O-])CSC­CC(=O)[O-])CSC­CC(=O)[O-])CSC­CC(=O)[O-])CSC­CC(=O)[O-])O)O)C(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]

Std­InChI

InChI=1S/C72H112O48S8.8Na/c73-33(74)1-9-121-17-25-57-41(89)49(97)65(105-25)114-58-26(18-122-10-2-34(75)76)107-67(51(99)43(58)91)116-60-28(20-124-12-4-36(79)80)109-69(53(101)45(60)93)118-62-30(22-126-14-6-38(83)84)111-71(55(103)47(62)95)120-64-32(24-128-16-8-40(87)88)112-72(56(104)48(64)96)119-63-31(23-127-15-7-39(85)86)110-70(54(102)46(63)94)117-61-29(21-125-13-5-37(81)82)108-68(52(100)44(61)92)115-59-27(19-123-11-3-35(77)78)106-66(113-57)50(98)42(59)90;;;;;;;;/h25-32,41-72,89-104H,1-24H2,(H,73,74)(H,75,76)(H,77,78)(H,79,80)(H,81,82)(H,83,84)(H,85,86)(H,87,88);;;;;;;;/q;8*+1/p-8/t25-,26-,27-,28-,29-,30-,31-,32-,41-,42-,43-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-;;;;;;;;/m1……../s1

Std­InChIKey

KMGK­ABOMYQLLDJ-VKHH­SAQN­SA-F

Mol­e­c­u­lar Formula

C72H104Na8O48S8

Mol­e­c­u­lar Weight

2178.006

Prop­er­ties

Appear­ance

White to off-white pow­der or granules

Safe­ty Data

WGK Germany

3

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our Sug­am­madex sodi­um CAS 343306-79-6

Iden­ti­fi­ca­tion Methods

IR, HPLC

Assay(on anhy­drous and no ethanol basis)

SUG∶ 89.0%~102.0%
SUG-OH∶ 0%~5.0%
SUG+SUG-OH∶ 94.0~102.0%
Na : 7.0%~9.0%

Fe

≤30ppm

Heavy Met­als

≤10ppm

Water

≤10%

Relat­ed sub­stances(HPLC)

SUG­ˉIMB : ≤ 0.3%
SUG-IMC : ≤ 0.3%
SUG-IMD : ≤ 0.20%
SUG-IMJ : ≤ 0.15%
SUG-IMK : ≤ 0.15%
SUG-IM0 : ≤ 0.10%
SUG­ˉIMR : ≤ 0,15%
Sin­gle unspec­i­fied impu­ri­ty : ≤ 0.10%
Total impu­ri­ties : ≤ 2.0%

Residue Sol­vents

Methanol : ≤300ppm
Ethanol : ≤50000ppm
DMF : ≤100ppm
DMSO : ≤500ppm

Micro­bi­o­log­i­cal examination

TAMC : ≤ 1000CFU/g(max.acceptable count=2000)

TYMC : ≤ 100CFU/g(max.acceptable count=200)

Bac­te­r­i­al endotoxin

≤0.3EU/​mg

Shelf Life

2 years

Stor­age

Under room tem­per­a­ture away from light

Known Appli­ca­tion

Sodi­um Glu­cosamine is used to reverse neu­ro­mus­cu­lar block­ade after admin­is­tra­tion of a non-depo­lar­iz­ing neu­ro­mus­cu­lar block­er such as vecuro­ni­um or rocuronium.

This prod­uct is devel­oped by our R&D com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Ltd(http://​www​.cam​ing​.com/), and here is the cor­re­spond­ing linkhttp://​www​.cam​ing​.com/​s​u​g​a​m​m​a​d​e​x​-​s​o​d​i​u​m​-​c​a​s​-​3​4​3​3​0​6​-​7​9​-6/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you short­ly (Please change screen to hor­i­zon­tal for com­plete brows­ing if you are check­ing Wat­son on your mobile phone). 

























    Please prove you are human by select­ing the key.